SynAct Pharma AB (STO:SYNACT)
Sweden · Delayed Price · Currency is SEK 17.26
+0.38 (2.25%)
Mar 23, 2026, 1:56 PM CET
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 945.31 million as of March 23, 2026. Its market cap has increased by 11.04% in one year.
Market Cap
945.31M
Enterprise Value
893.11M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
17.26
Market Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 945.31M, an increase of 1,382.79%. That is a compound annual growth rate of 32.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 945.31M | -21.57% |
| Dec 30, 2025 | 1.21B | 189.20% |
| Dec 30, 2024 | 416.76M | 32.69% |
| Dec 29, 2023 | 314.09M | -87.00% |
| Dec 30, 2022 | 2.42B | -34.75% |
| Dec 30, 2021 | 3.70B | 242.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 11, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Saniona AB | 2.08B |
| Egetis Therapeutics AB | 1.97B |
| Diamyd Medical AB | 1.87B |
| BioInvent International AB | 1.43B |
| Medivir AB | 1.16B |
| Xspray Pharma AB | 1.11B |
| Genovis AB (publ.) | 1.07B |
| Cantargia AB | 959.64M |